Published in J Perinatol on September 01, 2014
Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics (2010) 9.15
Vitamin A supplementation for extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med (1999) 3.11
Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics (2006) 2.86
Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase. Pediatrics (2003) 2.20
Pulmonary outcome in former preterm, very low birth weight children with bronchopulmonary dysplasia: a case-control follow-up at school age. J Pediatr (2013) 1.94
Intercenter differences in bronchopulmonary dysplasia or death among very low birth weight infants. Pediatrics (2010) 1.21
Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics (2005) 1.16
Long-term pulmonary outcomes of patients with bronchopulmonary dysplasia. Semin Perinatol (2013) 1.11
Neonatal drug development. Early Hum Dev (2011) 1.05
Respiratory outcomes for the tiniest or most immature infants. Semin Fetal Neonatal Med (2013) 0.97
The need for rigorous evidence on medication use in preterm infants: is it time for a neonatal rule? JAMA (2012) 0.94
A systematic review of randomized controlled trials for the prevention of bronchopulmonary dysplasia in infants. J Perinatol (2014) 0.92
Ethical issues in neonatal and pediatric clinical trials. Pediatr Clin North Am (2012) 0.86
Ethical challenges in neonatal research: Summary report of the ethics group of the newborn drug development initiative. Clin Ther (2006) 0.84
Federal legislation and the advancement of neonatal drug studies. J Pediatr (2012) 0.83
Drug studies in newborns: a therapeutic imperative. Clin Perinatol (2012) 0.83